This blog raises a number of questions about who would have access to extended parental leave if Artificial Amniotic and Placenta Technology is used.
Artificial Amnion and Placenta Technology provides an example of how the EU maternity leave framework is unable to support modern pregnancies.
While UK equality law does not yet clearly include those engaged in ART treatments, potential amendments could facilitate new interpretations.
While there are many upsides, employers should be mindful of how funding egg freezing may impact workplace culture.
Recent developments show the precarious relationship between Israel’s reproductive law and family units headed by single men and male same-sex couples.
Central to the legal framework of altruistic surrogacy is a highly gendered devaluation of labor.
Barriers include unequal access to treatment, as well as workplace laws and policies that discourage people from seeking treatment.
Should U.K. employers be required to make reasonable adjustments for women who are going through fertility treatment?
While egg freezing goes a long way toward relieving anxiety and sustaining hope, it also allows for conformity to heteropatriarchy and bionormativity.
The protective rationale of parental leave should be extended to address the needs for those undergoing fertility treatment.
